-+ 0.00%
-+ 0.00%
-+ 0.00%

Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share buyback at HKD 17.71 each

PUBT·07/17/2026 10:06:19
Listen to the news
Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share buyback at HKD 17.71 each
  • Shanghai Bao Pharmaceuticals repurchased 112,600 H shares on July 17, 2026 for treasury.
  • Buyback price range HKD 17.43 to HKD 17.91; aggregate consideration HKD 1.99 million.
  • No shares were repurchased for cancellation; treasury shares rose to 1,148,600.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Bao Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248185), on July 17, 2026, and is solely responsible for the information contained therein.